Canada markets closed

Evofem Biosciences, Inc. (EVFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4100+0.0203 (+5.21%)
At close: 04:00PM EST
0.4100 0.00 (0.00%)
After hours: 07:35PM EST

Evofem Biosciences, Inc.

12400 High Bluff Drive
Suite 600
San Diego, CA 92130
United States
858 550 1900

Full Time Employees147

Key Executives

NameTitlePayExercisedYear Born
Ms. Saundra PelletierPres, CEO & Director1.84MN/A1970
Mr. Justin J. FileChief Financial Officer1.01MN/A1970
Mr. Russell BarransChief Commercial Officer762.98kN/A1960
Ms. Amy RaskopfVP of Investor RelationsN/AN/AN/A
Mr. Alexander A. Fitzpatrick Esq.Exec. VP, Gen. Counsel & Sec.N/AN/A1967
Kathy Gallo-DoyleVP of SalesN/AN/AN/A
Dr. Kelly Culwell M.D.Chief Medical OfficerN/AN/A1974
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Corporate Governance

Evofem Biosciences, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.